Testing the Neuroscience of Guided Learning in Depression
NCT ID: NCT03203954
Last Updated: 2022-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
216 participants
INTERVENTIONAL
2016-05-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Control Training for Remitted Depressed Patients
NCT02407652
Online Cognitive Control Training for Remitted Depressed Patients
NCT03278756
Therapist-Guided Smartphone-Delivered CBT for MDD
NCT05386329
Predictors of Treatment Outcome With Cognitive Behavioral Therapy for Depression
NCT01922219
Treatment of Post-TBI Depression
NCT00211835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To address these issues, the investigators use functional neuroimaging and a computational psychiatry framework to i) systematically characterize the neural and behavioral substrates that attend reward- and loss- learning in depression and ii) assess the degree to which learning in depression responds to two behavioral methods that target learning in different ways. The investigators test the broad hypotheses that i) that depression may be characterized by distinct neural and behavioral disruptions of learning, and ii) these disruptions and associated symptoms may be ameliorated through different methods of guiding learning. Recent advances in computational psychiatry provide a mechanism-based framework within which to understand the nature and trajectory of potential learning impairments in depression and suggest new ways that disrupted learning and associated symptoms may be improved in depression
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Training
Guided learning, standard learning: Repeat administration of standard behavioral learning task
Standard Learning
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
Instructed Statistics
Guided learning, instructed statistics: Repeat administration of behavioral learning task with instructions about task statistics
Guided Learning: Instructed statistics
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
Not Instructed Statistics
Guided learning, changing statistics: Repeat administration of behavioral learning task with changing task statistics
Guided Learning: Changing statistics
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Learning
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
Guided Learning: Instructed statistics
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
Guided Learning: Changing statistics
Participants will complete repeat sessions of a computer-based learning task, and task performance and symptoms will be assessed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* meet diagnostic criteria for major depression or non-depressed control (assessed by study staff)
* ages 18-55
* fluent in English
* able to see computer display clearly
* able to provide informed consent
* able to follow verbal or written instructions
* for participants who are referred by a clinician, a letter from that clinician indicating that participation in the study does not constitute an elevated medical or behavioral risk to the participant will be requested.
Exclusion Criteria
* claustrophobia
* MRI contraindications
* psychotic or bipolar disorder
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Virginia Polytechnic Institute and State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pearl Chiu
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Tech Carilion Research Institute
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDDLEARNING
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.